Table 1 Characteristics and distributions of physiotherapy related interventions in children with cerebral palsy
Variable, n = available data | Boys, n (%) | Girls, n (%) | Total, n (%) |
|---|---|---|---|
Physiotherapy assessment form, N = 2635 | |||
 Place of birth, n = 2635 | |||
  Nordic country | 1305 (85.4) | 924 (83.5) | 2229 (84.6) |
  Outside of the Nordic countries | 223 (14.6) | 183 (16.5) | 406 (15.4) |
 Gross Motor Function Classification System levels, n = 2635 | |||
  I | 699 (45.7) | 508 (45.9) | 1207 (45.8) |
  II | 263 (17.2) | 190 (17.2) | 453 (17.2) |
  III | 156 (10.2) | 113 (10.2) | 269 (10.2) |
  IV | 223 (14.6) | 150 (13.6) | 373 (14.2) |
  V | 187 (12.2) | 146 (13.2) | 333 (12.6) |
Spasticity score, mean (SD), range, n = 2534 | 18.75 (16.29), 0–95.83 | 17.68 (15.15), 0–87.5 | 18.30 (15.83), 0–95.83 |
 Received botulinum toxin A in the lower extremities since the last CPUP*assessment, n = 2500 | |||
  Yes | 304 (21.0) | 187 (17.8) | 491 (19.6) |
 Intrathecal baclofen (pump), n = 2343 | |||
  Yes | 38 (2.8) | 15 (1.5) | 53 (2.3) |
 Spasticity reducing medication (oral), n = 2467 | |||
  Yes | 103 (7.2) | 74 (7.1) | 177 (7.2) |
 Selective dorsal rhizotomy, n = 1944 | |||
  Yes | 45 (4.0) | 15 (1.9) | 60 (3.1) |
 Received physiotherapy treatment since last CPUP* assessment | |||
  Yes | 1076 (72.5) | 785 (73.0) | 1861 (72.7) |
Use of spinal brace, n = 2550 | |||
  Yes | 124 (8.4) | 100 (9.4) | 224 (8.8) |
 Assistive device to facilitate standing, n = 2423 | |||
  Yes | 421 (30.1) | 308 (30.1) | 729 (30.1) |